In the video below, psoriasis experts, Professor Catherine Smith and Dr Satveer Mahil of St John’s Institute of Dermatology in London introduce PsoProtectMe – a new survey to support vital research into COVID-19 and psoriasis.
Questions answered in this video include:
- What is PsoProtectMe, and why is it important? (0:20)
- Who should take part in PsoProtectMe? (1:25)
- How can people take part and what will they need to do? (2:17)
- Can patients revisit the survey if they catch COVID-19 after completing it initially? (4:12)
- How will participants’ data be stored and can they withdraw it if they change their mind at a later date? (5:02)
Psoriasis Association is honoured to be collaborating once more with
world leading experts on psoriasis at the St John’s Institute of
Dermatology, Guy’s and St Thomas’ NHS Foundation Trust, London
and the University of Manchester on a vital piece of research
regarding psoriasis and COVID-19 (coronavirus).
is an online survey for people with psoriasis to complete,
irrespective of whether you have symptoms of COVID-19 or not.
are asking everyone with psoriasis to complete this important online
survey, or to ask a friend or family member to complete it on your
behalf. The online PsoProtectMe survey takes only 5-10 minutes to complete and asks about your symptoms,
psoriasis treatments and any underlying health conditions you may
have. If you have suffered from COVID-19, you will be asked how this
has affected you and your psoriasis. If in the future you develop
COVID-19 we would ask that you revisit the survey (you will be
provided with a unique reference number at the end) and let us know
of your experience.
do complete the survey irrespective of the type or severity of
psoriasis you have, whether you are currently treating your psoriasis
or not. We need all ages to complete the survey in order to build an
information will help us understand how the COVID-19 pandemic is
affecting people with psoriasis, and whether the treatments used for
psoriasis increase or decrease the risk of severe COVID-19 infection.
This will help healthcare professionals make important decisions
about the clinical care of people with psoriasis during the pandemic.
Which is why, even if you are well and have not had any symptoms of
COVID-19 we really need you to answer this survey call. It could be
that your treatment is beneficial in helping protect people from
COVID-19 or it could be that one type, or severity of psoriasis
affects the body’s response to this virus.
contribution will benefit everyone – please help by completing the
PsoProtectMe survey today.
McAteer, Chief Executive of the Psoriasis Association commented, “Whilst the COVID-19 pandemic
has been a worrying time for us all, it has again shown the strength
of the psoriasis community that registries such as PsoProtect and now
PsoProtectMe have been established so quickly to help further our
understanding and treat people with psoriasis and COVID-19. The
commitment of the teams at the St John’s Institute of Dermatology
and the University of Manchester, with support from the Psoriasis
Association is essential to the understanding not just of psoriasis,
but all health events that may affect people living with the
condition. Please do give 5-10 minutes to complete the survey –
your information really is important.”